Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Vues
• 08/09/23
0
0
Intégrer
administrator
Les abonnés
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires